GileadThe experimental twice-yearly HIV prevention drug was 100% effective in a late-stage study, the corporate ...
The Food and Drug Administration on Monday approved MerckThe recent vaccine is meant to guard ...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding the vaccination's reach
The Food and Drug Administration on Friday approved GSKRespiratory syncytial virus vaccine for adults aged ...
Modern And Merck publishes more positive Three-year data Monday about their experimental vaccine, which is ...
The Food and Drug Administration approved on Friday Modern Respiratory syncytial virus vaccine for adults ...
Modern said Friday that the Food and Drug Administration has delayed approval of its respiratory ...
Novavax On Friday it said it had signed one billion dollar deal with the French ...
Modern reported a narrower-than-expected first-quarter loss on Thursday as the corporate's cost-cutting efforts took effect ...
Brain tumors remain amongst essentially the most difficult tumors to treat. They often don’t respond ...
A team of Montana researchers is playing a key role in developing a simpler vaccine ...